3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Conditions
Multiple Myeloma
16
Recurrence
3
Neoplasms, Plasma Cell
2
Renal Insufficiency
1
Paraproteinemias
1
Neoplasms by Histologic Type
1
Neoplasms
1
Immunoglobulin Light-chain Amyloidosis
1
Hypoxia
1
High Grade Squamous Intra-epithelial Lesion (HSIL)
1
Hematologic Diseases
1
Disease Progression
1
Blood Protein Disorders
1
Amyloidosis
1
Interventions
pomalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
High Grade Squamous Intra-epithelial Lesion (HSIL)
×
pomalidomide
×
Clear all
NCT03113942
2022-03-31
SPACE
Kirby Institute
Phase 2
Unknown
26 enrolled